AU Stock MarketDetailed Quotes

PAB Patrys Ltd

Watchlist
  • 0.002
  • 0.0000.00%
20min DelayTrading Apr 30 10:06 AET
4.11MMarket Cap-1.00P/E (Static)

About Patrys Ltd Company

Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.

Company Profile

SymbolPAB
Company NamePatrys Ltd
Founded2006
MarketASX
Fiscal Year Ends06-30
AddressLevel 4, 100 Albert Road South Melbourne
CityMelbourne
CountryAustralia
Zip Code3205
Phone+61 396703273
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067 03 9415 4000

Company Executives

  • Name
  • Position
  • Salary
  • James Campbell
  • Chief Executive Officer,Managing Director
  • --
  • Michael Stork
  • Non-Executive Director,Non-Executive Deputy Chairman
  • --
  • Charmaine Gittleson
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Pamela M Klein
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More